文献速递中药与中成药合理使用中医内科

槲寄生属植物潜在治疗应用的资源综述

Exploring the resources of the genus Viscum for potential therapeutic applications.
PubMed 文献 · J Ethnopharmacol · 2021-05-24

本文系统综述了槲寄生属12个物种的药用研究,涵盖从1915年至2021年4月的文献。已报道至少250种化合物,包括凝集素、黏毒素、黄酮、萜类等活性成分,具有抗癌、抗风湿、抗炎等生物活性,并讨论了基于活性成分的质量控制方法。

要点

  • 槲寄生属植物提取物广泛用于风湿和癌症的补充替代治疗。
  • 12个物种中至少报道250种化合物,活性成分包括凝集素、黏毒素、黄酮等。
  • 活性成分具有抗癌、抗风湿、抗炎、免疫增强等生物活性。

核心结论

  • 槲寄生属是值得在药理和化学研究中进一步开发的重要药用资源。

研究设计与样本

  • 综述检索PubMed、CNKI、Google Scholar和Web of Science从1915年1月至2021年4月的在线信息,并结合中药经典书籍,覆盖12个槲寄生属物种。

主要发现

  • 12个物种中至少报道250种不同化合物,包括氨基酸和肽类、生物碱、酚酸、黄酮、萜类、碳水化合物、脂肪酸、脂质等。
  • 对槲寄生(Viscum coloratum)和欧洲槲寄生(Viscum album)的植物、制剂和活性成分已有全面综述。
  • 活性成分包括凝集素、黏毒素、黄酮、萜类、酚酸和多糖,参与抗癌、抗风湿关节痛、抗炎、抗心血管疾病、增强免疫和抗化疗副作用等多种生物活性。

关键数值与推荐

  • 评估了基于活性化合物、体内暴露化合物和区分性化学标志物的质量控制方法。

临床怎么用

  • 槲寄生属植物在临床上安全性和有效性显著且副作用小,可作为补充替代药物用于风湿和癌症相关治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: The genus Viscum comprises approximately 100 species that are mainly distributed across Africa, Asia and Europe. The extracts and preparations of Viscum species are widely used as common complementary and alternative medicines in the treatment of rheumatism and cancer. AIM OF THE REVIEW: This review aims to explore the medicinal properties of twelve species belonging to the genus Viscum for potential therapeutic applications. MATERIALS AND METHODS: We collected online information (including PubMed, CNKI, Google Scholar, and Web of Science) from January 1915 to April 2021 and knowledge from classical books on Chinese herbal medicines available for 12 species of the genus Viscum, including Viscum coloratum (Kom.) Nakai, Viscum album L., Viscum articulatum Burm. f., Viscum liquidambaricola Hayata, Viscum ovalifolium DC., Viscum capitellatum Sm., Viscum cruciatum Sieber ex Boiss., Viscum nudum Danser, Viscum angulatum B.Heyne ex DC., Viscum tuberculatum A.Rich., Viscum multinerve Hayata, and Viscum diospyrosicola Hayata. RESULTS: At least 250 different compounds have been reported across twelve Viscum species, including amino acid and peptides, alkaloids, phenolic acids, flavonoids, terpenoids, carbohydrates, fatty acids, lipids, and other types of compounds. In particular, for Viscum coloratum (Kom.) Nakai and Viscum album L., the plants, preparations, and bioactive components have been thoroughly reviewed. This has allowed to elucidate the role of active components, including lectins, viscotoxins, flavonoids, terpenoids, phenolic acids, and polysaccharides, in multiple bioactivities, such as anti-cancer, anti-rheumatism arthralgia, anti-inflammation, anti-cardiovascular diseases, enhancing immunity, and anti-chemotherapy side effects. We also evaluated quality control methods based on active compounds, in vivo exposure compounds, and discriminated chemical markers. CONCLUSIONS: This is the first report to systematically review the pharmaceutical development history, chemical composition, clinical evidence, pharmacological activity, discriminated chemical markers, in vivo exposure, and quality control on twelve distinct species of Viscum plants with medicinal properties. The significant safety and efficacy, along with the minor side effects are constantly confirmed in clinics. The genus Viscum is thus an important medicinal resource that is worth exploring and developing in future pharmacological and chemical studies.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Song C, Wei XY, Qiu ZD, et al. Exploring the resources of the genus Viscum for potential therapeutic applications. J Ethnopharmacol. 2021. PMID: 34044077. doi:10.1016/j.jep.2021.114233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。